Company intelligence / Profile preview

DiscoveryBioMed

Birmingham, Alabama, United Stateseurofins.com ↗

Ownership: Private
Development stage: Preclinical

Overview

DiscoveryBioMed specialized in developing physiologically relevant human cell platforms for drug discovery, offering both proprietary R&D and fee-for-service work. The company contributed to the identification of clinical candidates but did not advance its own programs into late-stage clinical trials before acquisition. Its patents include methods for treating kidney diseases using small molecules such as coumarin derivatives.

Therapeutic areas: OncologyNephrology
Modalities: Cell-based assaySmall molecule
Industry: Drug Discovery Services

Beyond the preview

Go deeper on DiscoveryBioMed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DiscoveryBioMed.

Explore the full profile